drugset / Trial / NCT02097004

Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection

NCT02097004

Phase 4 Completed 111 enrolled Seoul National University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

A randomized, Open label, Single center, Prospective study to compare efficacy and safety of Therapeutic Vaccination with Intensified schedule plus Pegylated Interferon dual Therapy on Seroclearance of Hepatitis B virus Surface Antigen in Patients with Complete Virological Response Induced by Entecavir

Timeline

Start
2014-04
Primary completion
2018-01
Completion
2018-03-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Euvax B Inj Vaccine 20 ug Intramuscular
Subject Peginterferon alfa-2a Protein / enzyme biologic 180 ug Subcutaneous
Background Entecavir Small molecule 0.5 mg